URL | https://www.biopharminternational.com/view/croda-p |
Source | Bio Pharma International.com |
Date Published | 06/14/2023 |
Author Name | Grant Playter |
Company/Division name | Croda Pharma |
Parent company | Croda Pharma |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2023 |
Year reshoring implemented or to be implemented: | 2025 |
City reshored to: | Lamar |
State(s) reshored to: | PA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | mRNA vaccines and gene editing therapies |
What domestic positive factors made reshoring more attractive? | Eco-system synergies |